Pfizer Inc. (NYSE:PFE) shares moved up 5.01% in last trading session and ended the day at $32.93. PFE Gross Margin is 80.40% and its has a return on assets of 5.70%. Pfizer Inc. (NYSE:PFE) quarterly performance is 3.36%.
Pfizer Inc. (NYSE: PFE) announced that the merger agreement between Pfizer and Allergan plc (NYSE: AGN) has been terminated by mutual agreement of the companies. The decision was driven by the actions announced by the U.S. Department of Treasury on April 4, 2016, which the companies concluded qualified as an “Adverse Tax Law Change” under the merger agreement.
Bank of the Ozarks, Inc. (NASDAQ:OZRK) ended the last trading day at $42.21. Company weekly volatility is calculated as 2.57% and price to cash ratio as 41.79. Bank of the Ozarks, Inc. (NASDAQ:OZRK) showed a weekly performance of 0.12%.
Bank of the Ozarks (NASDAQ: OZRK) declared a quarterly dividend of $0.155 per share, or $0.62 annualized. This is a 3.3% increase from the prior dividend of $0.15. The dividend will be payable on April 22, 2016, to stockholders of record on April 15, 2016, with an ex-dividend date of April 13, 2016.
On 06 April, TCF Financial Corporation (NYSE:TCB) shares moved up 1.35% and was closed at $12.03. TCB EPS growth in last 5 year was -0.20%. TCF Financial Corporation (NYSE:TCB) year to date (YTD) performance is -14.22%.
TCF Financial Corporation (TCF) (NYSE: TCB) announced it will release its first quarter 2016 earnings results before the market opens on Thursday, April 21, 2016. Craig R. Dahl, president and chief executive officer, will host a conference call to discuss the results at 9:00 a.m. Central Daylight Time and will be joined by other TCF executives.
Sears Holdings Corporation (NASDAQ:SHLD) shares advanced 0.82% in last trading session and ended the day at $14.70. SHLD Gross Margin is 23.30% and its has a return on assets of -8.90%. Sears Holdings Corporation (NASDAQ:SHLD) quarterly performance is -26.32%.
On 28 March, Sears Holdings (NASDAQ:SHLD) announced that James P. Andrew has joined the company in the new role of Chief Administrative Officer. In this position he will be responsible for the company’s corporate support functions, including financial planning and analysis, business finance, procurement, legal, and human resources.
Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) caters to the Healthcare space. Its weekly performance is 25.79%. On the last day of trading company shares ended up at $2.39.
On 22 March, Pieris Pharmaceuticals Inc. (NASDAQ:PIRS) reported a loss of $2.9 million in its fourth quarter. The Freising-Weihenstephan, Germany-based company said it had a loss of 7 cents per share. The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 13 cents per share. The biopharmaceutical company posted revenue of $2.1 million in the period.
Leave a Reply